Report Feature
The future of the functional genomic market looks promising with opportunities in clinical and research laboratories, academic and government institutes, hospitals and clinics, and pharmaceutical & biotechnology companies. The global functional genomic market is expected to grow with a CAGR of XX% from 2020 to 2025. The major drivers for this market are constantly reducing prices of genetic procedures and rising usage of genomics in R&D of new drugs.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global functional genomic market report, please download the report brochure.
In this market, PCR is the largest technology segment of functional genomic, whereas pharmaceutical & biotechnology companies is the fastest growing application. Growth in various segments of the functional genomic market are given below:
The study includes trends and forecast for the global functional genomic market by deliverable, technology, end user, and region as follows:
By Deliverable [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Products
- Instruments and Softwares
- Consumables and Reagents
-
Services
- Core Genomics Services
- NGS-based Services
- Biomarker Translation Services
- Computational Services
- Others
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- Polymerase Chain Reaction (PCR)
- Sequencing
- Microarray
- Nucleic Acid Extraction and Purification
- Other Technologies
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Clinical and Research Laboratories
- Academic and Government Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the functional genomic companies profiled in this report include Thermo Fisher Scientific, Agilent Technologies, Eppendorf, and Bio-Rad Laboratories.
Lucintel forecasts that PCR will remain the largest technology segment over the forecast period due to rising research activities and low cost of DNA (Deoxyribonucleic Acid) amplification using PCR.
Within this market, pharmaceutical and biotechnology companies will remain the largest end user segment over the forecast period due to rising genetic research studies for development of drugs with fewer side effects and improving drug discovery process.
North America will remain the largest region over the forecast period due to rising investment in research by government organizations and presence of advanced healthcare infrastructure in the region.
|
Features of the Global Functional Genomic Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global functional genomic market by deliverable (products (instruments & softwares and consumables & reagents) and services (core genomics services, NGS-based services, biomarker translation services, computational services, and others)), technology (PCR, sequencing, microarray, nucleic acid extraction and purification, and other technologies), end user (clinical & research laboratories, academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global functional genomic market? Q.5 What are the business risks and threats to the global functional genomic market? Q.6 What are the emerging trends in this functional genomic market and the reasons behind them? Q.7 What are some changing demands of customers in this functional genomic market? Q.8 What are the new developments in this functional genomic market? Which companies are leading these developments? Q.9 Who are the major players in this functional genomic market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this functional genomic market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global functional genomic market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Deliverable (Products (Instruments & Softwares and Consumables & Reagents) and Services (Core Genomics Services, NGS-Based Services, Biomarker Translation Services, Computational Services, and Others)), Technology (PCR, Sequencing, Microarray, Nucleic Acid Extraction And Purification, and Other Technologies), and End User (Clinical & Research Laboratories, Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Other End Users) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Functional Genomic Market
4.1 Global Functional Genomic Market by Region
4.2.1 Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.2.2 Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.2.3 Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.2.4 The United States Functional Genomic Market
4.2.5 The Canadian Functional Genomic Market
4.2.6 The Mexican Functional Genomic Market
4.3.1 Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.3.2 Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.3.3 Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.3.4 The Functional Genomic Market of United Kingdom
4.3.5 The German Functional Genomic Market
4.3.6 The French Functional Genomic Market
4.4.1 Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.4.2 Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.4.3 Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.4.4 The Chinese Functional Genomic Market
4.4.5 The Indian Functional Genomic Market
4.4.6 The Japanese Functional Genomic Market
4.5.1 Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.5.2 Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.5.3 Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.5.4 Brazilian Functional Genomic Market
7.1.1 Growth Opportunities for the Global Functional Genomic Market by Deliverable
7.1.2 Growth Opportunities for the Global Functional Genomic Market by Technology
7.1.3 Growth Opportunities for the Global Functional Genomic Market by End User
7.1.4 Growth Opportunities for the Global Functional Genomic Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
